Published in Lab Law Weekly, February 2nd, 2007
The authorized generic product will be distributed by Watson in both the 2.5 mg and 10 mg dosages. The A-B rated authorized generic of oxandrolone tablets will continue to meet all quality control standards of the Oxandrin brand and will contain the same active and inactive pharmaceutical ingredients. Oxandrin is Savient's oral anabolic agent for the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.